Abstract
Leishmaniasis is defined as a cluster of infectious diseases caused by protozoan parasites of the genus Leishmania. It is recognized worldwide as a major health problem, showing high endemicity in developing countries. The present review details this complex group of neglected diseases, with important clinical spectrum and large epidemiological diversity, and discusses the evolution of leishmaniasis treatment and the urgent need for less toxic, more specific and effective drugs against these parasites. Finally, the value of natural products and synthetic derivatives as rich sources of antileishmanial drug candidates is demonstrated, indicating a promising approach for the development of novel therapeutic alternatives.
Keywords: Antileishmanial drugs, Leishmania, Leishmaniasis, Leishmaniasis treatment, natural products, neglected diseases, thiourea.
Graphical Abstract
Current Biotechnology
Title:Leishmaniasis: History, Evolution of Treatment and the Need for New Drugs
Volume: 3 Issue: 4
Author(s): Elisama Azevedo Cardoso, Aldo Rodrigues da Silva, Gabriela Cristina de Carvalho, Aline Guerra Manssour Fraga, Maria Leticia de Castro Barbosa, Andre Luis Souza dos Santos, Helena Carla Castro and Viviane Lione
Affiliation:
Keywords: Antileishmanial drugs, Leishmania, Leishmaniasis, Leishmaniasis treatment, natural products, neglected diseases, thiourea.
Abstract: Leishmaniasis is defined as a cluster of infectious diseases caused by protozoan parasites of the genus Leishmania. It is recognized worldwide as a major health problem, showing high endemicity in developing countries. The present review details this complex group of neglected diseases, with important clinical spectrum and large epidemiological diversity, and discusses the evolution of leishmaniasis treatment and the urgent need for less toxic, more specific and effective drugs against these parasites. Finally, the value of natural products and synthetic derivatives as rich sources of antileishmanial drug candidates is demonstrated, indicating a promising approach for the development of novel therapeutic alternatives.
Export Options
About this article
Cite this article as:
Cardoso Azevedo Elisama, Silva Rodrigues da Aldo, Carvalho Cristina de Gabriela, Fraga Guerra Manssour Aline, Barbosa Leticia de Castro Maria, Santos Luis Souza dos Andre, Castro Carla Helena and Lione Viviane, Leishmaniasis: History, Evolution of Treatment and the Need for New Drugs, Current Biotechnology 2014; 3 (4) . https://dx.doi.org/10.2174/2211550104666150303231736
DOI https://dx.doi.org/10.2174/2211550104666150303231736 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Designer Drugs (Synthetic Cannabinoids and Synthetic Cathinones): Review of Literature
Current Pharmaceutical Design Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future
Current Pharmaceutical Design Leukopenia Associated with Risperidone Treatment
Current Drug Safety Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
Current Alzheimer Research Selection Criteria for Probiotics and Potential of Cereal Based Food Products as Novel Probiotic-Carriers
Current Nutrition & Food Science Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain – Sciatica
CNS & Neurological Disorders - Drug Targets Effects of Maternal Obesity on Maternal and Fetal Health
Current Women`s Health Reviews Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry Illicit Methylphenidate Use: A Review of Prevalence, Availability, Pharmacology, and Consequences
Current Drug Abuse Reviews Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Lagenaria siceraria: A Potential Source of Anti-Hyperlipidemic and Other Pharmacological Agents
Current Nutrition & Food Science Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Recent Patents on CNS Drug Discovery (Discontinued) Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Current Drug Metabolism Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
Current Medicinal Chemistry Heterocyclic Amaryllidaceae Alkaloids: Biosynthesis and Pharmacological Applications
Current Topics in Medicinal Chemistry Cutaneous Complications of Anderson-Fabry Disease
Current Pharmaceutical Design